Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18624353 | ANTI-STAPHYLOCOCCUS AUREUS SPECIFIC ANTIBODY AND NUCLEIC ACID ENCODING SEQUENCE THEREOF, AND USES OF THE SAME | April 2024 | March 2025 | Allow | 12 | 1 | 1 | No | No |
| 18416083 | LACTOBACILLUS PARACASEI GLU70 STRAIN WITH GLUTEN-DEGRADING ABILITY AND ANTIBACTERIAL ACTIVITY AND PROBIOTIC PROPERTIES AND USES THEREOF | January 2024 | March 2025 | Abandon | 13 | 1 | 0 | No | No |
| 18503901 | LYOPHILIZED AND STABILIZED LIVE ATTENUATED FORMULATED VACCINE AGAINST TULAREMIA | November 2023 | March 2025 | Allow | 16 | 2 | 0 | Yes | No |
| 17765428 | NON-TOXIC LISTERIOLYSIN O POLYPEPTIDES AND USES THEREOF | March 2022 | March 2025 | Abandon | 36 | 0 | 1 | No | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner MORGAN, BAILEY MICHELLE works in Art Unit 1645 and has examined 2 patent applications in our dataset. With an allowance rate of 50.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.
Examiner MORGAN, BAILEY MICHELLE's allowance rate of 50.0% places them in the 7% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by MORGAN, BAILEY MICHELLE receive 1.00 office actions before reaching final disposition. This places the examiner in the 12% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by MORGAN, BAILEY MICHELLE is 36 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +100.0% benefit to allowance rate for applications examined by MORGAN, BAILEY MICHELLE. This interview benefit is in the 100% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
This examiner enters after-final amendments leading to allowance in 100.0% of cases where such amendments are filed. This entry rate is in the 99% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.